CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility
- PMID: 20133979
CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility
Abstract
Background: Breast cancer is the commonest cancer among women in industrialized countries. Most sporadic breast carcinomas are likely to be caused by low-penetrance genes. Genes encoding enzymes involved in estrogen and carcinogen metabolism are among these low-penetrance genes. In this study, for the first time the T/C (A1/A2) polymorphism at the 5' untranslated region (UTR) of CYP17 and the Arg/Trp (T/C) polymorphism at codon 39 of CYP19 among genes regulating endogenous estrogen levels was studied.
Patients and methods: Fifty-five female breast cancer patients and ninety-one controls took part in the study. DNA was extracted from paraffin-embedded tissues for the patients and from blood cells for the controls. The distribution of genotypes was determined using polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) techniques.
Results: The frequency of the TC genotype of CYP19 was significantly higher in the patient group (p<0.001, kappa(2): 12.31, OR: 7.30, 95% CI: 2.29-25.64). CYP17 frequencies were similar to those in Caucasian populations. In combined analysis, when the high risk alleles were evaluated together, the results reached significance (p=0.006, kappa(2)=7.01, OR: 2.53, %95 CI: 1.26-5.07) for the A2 allele of CYP17 and the C allele of CYP19, being more frequent in the patient group compared to the control. The risk possesed by the TC varient of CYP19 was reduced when evaluated with A1, the protective allele of CYP17 (p=0.082). The cumulative protective effects of both A1 allele and the TT genotype were ascertained to occur significantly less frequently in the patient group (p=0.001, kappa(2): 10.53, OR: 8.47, %95 CI: 1.9-37.04).
Conclusion: The results were consistent with the individual studies of CYP17 and CYP19 in the literature, however, in combined analysis of the alleles of the two genes, the frequency of high risk alleles was higher and the frequencies of low risk alleles were lower in the patient group. The CYP17 A1 + CYP19 TT haplotype may be protective for breast cancer.
Similar articles
-
The CYP17 and CYP19 gene single nucleotide polymorphism in women with sporadic breast cancer.Pol J Pathol. 2009;60(4):163-7. Pol J Pathol. 2009. PMID: 20072949
-
Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.Breast Cancer Res Treat. 2009 Mar;114(2):327-38. doi: 10.1007/s10549-008-9998-0. Epub 2008 Jul 16. Breast Cancer Res Treat. 2009. PMID: 18629629
-
The T/C polymorphism of the CYP17 gene and G/A polymorphism of the CYP19 gene in endometrial cancer.J Exp Clin Cancer Res. 2006 Sep;25(3):411-6. J Exp Clin Cancer Res. 2006. PMID: 17167982
-
Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women.Biomed Pharmacother. 2003 Dec;57(10):471-81. doi: 10.1016/j.biopha.2003.09.008. Biomed Pharmacother. 2003. PMID: 14637391 Review.
-
Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism.Mutat Res. 2003 Sep;544(1):9-41. doi: 10.1016/s1383-5742(03)00016-4. Mutat Res. 2003. PMID: 12888106 Review.
Cited by
-
Association between CYP17 T-34C rs743572 and breast cancer risk.Oncotarget. 2017 Dec 26;9(3):4200-4213. doi: 10.18632/oncotarget.23688. eCollection 2018 Jan 9. Oncotarget. 2017. PMID: 29423115 Free PMC article.
-
Association between CYP17A1 rs743572 polymorphism and cancer risk: A meta-analysis.PLoS One. 2025 Jun 25;20(6):e0326843. doi: 10.1371/journal.pone.0326843. eCollection 2025. PLoS One. 2025. PMID: 40561159 Free PMC article.
-
CYP17 MspA1 Gene Polymorphism and Breast Cancer Patients According to Age of Onset in Cancer Institute of Iran.Iran J Public Health. 2017 Apr;46(4):537-544. Iran J Public Health. 2017. PMID: 28540271 Free PMC article.
-
Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene Polymorphisms: A Review.Cells. 2024 Nov 26;13(23):1958. doi: 10.3390/cells13231958. Cells. 2024. PMID: 39682707 Free PMC article. Review.
-
CYP17 polymorphism (rs743572) is associated with increased risk of gallbladder cancer in tobacco users.Tumour Biol. 2014 Jul;35(7):6531-7. doi: 10.1007/s13277-014-1876-2. Epub 2014 Apr 1. Tumour Biol. 2014. PMID: 24687554
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical